Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Charles River Laboratories International, Inc. Common Stock
(NY:
CRL
)
301.79
+3.79 (+1.27%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Charles River Laboratories International, Inc. Common Stock
< Previous
1
2
...
16
17
18
19
20
21
22
23
Next >
Medpace Stock Shows Rising Price Performance With Jump To 83 RS Rating
↗
August 17, 2021
Medpace sees its Relative Strength Rating reach the 80-plus level.
Via
Investor's Business Daily
How Does Charles River's Debt Look?
↗
August 17, 2021
Shares of Charles River (NYSE:CRL) rose by 27.14% in the past three months. Before having a look at the importance of debt, let us look at how much debt Charles River has....
Via
Benzinga
Charles River Laboratories International, inc (CRL) Q2 2021 Earnings Call Transcript
↗
August 04, 2021
CRL earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Recap: Charles River Q2 Earnings
↗
August 04, 2021
Shares of Charles River (NYSE:CRL) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share increased 65.19% year over year to $2.61,...
Via
Benzinga
Charles River Laboratories Announces Second-Quarter 2021 Results
August 04, 2021
From
Charles River Laboratories International, Inc.
Via
Business Wire
Stocks That Hit 52-Week Highs On Thursday
↗
July 29, 2021
Thursday's morning session saw 167 companies set new 52-week highs. Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by market cap to set a new...
Via
Benzinga
Where Charles River Stands With Analysts
↗
July 20, 2021
Charles River (NYSE:CRL) has observed the following analyst ...
Via
Benzinga
Stocks That Hit 52-Week Highs On Thursday
↗
April 15, 2021
Thursday morning saw 166 companies set new 52-week highs. Interesting Highlights: The largest company by market cap to hit a new 52-week high was Microsoft (NASDAQ:...
Via
Benzinga
Charles River Laboratories Schedules Second-Quarter 2021 Earnings Release and Conference Call
July 13, 2021
From
Charles River Laboratories International, Inc.
Via
Business Wire
10 Top-Ranked Stocks Powering S&P 500 ETF
↗
July 08, 2021
Though most stocks in the fund’s portfolio have been in the deeper green so far this year, here are 10 stocks that led the rally.
Via
Talk Markets
Topics
Stocks
Charles River Laboratories Completes Acquisition of Vigene Biosciences
June 29, 2021
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River's Jim Foster Beat The Trauma Of Being CEO
↗
June 10, 2021
Think taking over the family business is easy? Charles River CEO Jim Foster might beg to differ. He's shown that being CEO comes with trauma.
Via
Investor's Business Daily
Stocks That Hit 52-Week Highs On Thursday
↗
June 17, 2021
This morning 94 companies set new 52-week highs. Things to Consider: NVIDIA (NASDAQ:NVDA) was the largest firm by market cap to set a new 52-week high. Deswell Industries...
Via
Benzinga
Bio-Techne Stock Shows Rising Strength As The Small Cap Nears Billion-Dollar Run Rate
↗
June 07, 2021
Bio-Techne's revenue grew 25% last quarter. Revenue growth has risen the past four quarters as it nears entry in the billion-dollar a year run-rate club.
Via
Investor's Business Daily
Charles River Laboratories Announces Long-Term Solar Contract for North American Operations
June 07, 2021
From
Charles River Laboratories International, Inc.
Via
Business Wire
Agilent Technologies Stock Shows Rising Relative Strength
↗
June 04, 2021
The Relative Strength (RS) Rating for Agilent Technologies stock moved up into a new percentile Friday, as it got a lift from 67 to 71.
Via
Investor's Business Daily
Charles River Laboratories to Participate in June Investor Conferences
May 28, 2021
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Host Virtual Investor Day
May 26, 2021
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Acquires Viral Vector Player For $350M
↗
May 17, 2021
Contract researcher Charles River Laboratories International Inc (NYSE: CRL) will dole out $292.5 million for gene therapy CDMO Vigene Biosciences with the...
Via
Benzinga
Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities
May 17, 2021
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Labs Joins Elite List Of Stocks With 95-Plus Composite Rating
↗
May 05, 2021
Charles River Labs' Accumulation/Distribution Rating of A, on an A+ to E scale, shows heavy buying by institutional investors over the last 13 weeks.
Via
Investor's Business Daily
Charles River Laboratories International Inc (CRL) Q1 2021 Earnings Call Transcript
↗
May 04, 2021
CRL earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Charles River: Q1 Earnings Insights
↗
May 04, 2021
Shares of Charles River (NYSE:CRL) decreased 0.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 37.50% year over...
Via
Benzinga
Charles River Laboratories Announces First-Quarter 2021 Results
May 04, 2021
From
Charles River Laboratories International, Inc.
Via
Business Wire
Three Medical Stocks To Watch, Including One With A Potential Breakout
↗
April 22, 2021
Two have recent breakouts under their belts while a third is eyeing a fresh buy point.
Via
Investor's Business Daily
Medpace Holdings Stock At The Top Of Buy Range With Earnings On Deck
↗
April 20, 2021
Medpace is in a potential buy range with its next earnings report scheduled for Apr. 26. The medical stock is about 3% above a 177.22 buy point from a second-stage... Read More
Via
Investor's Business Daily
Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call
April 13, 2021
From
Charles River Laboratories International, Inc.
Via
Business Wire
< Previous
1
2
...
16
17
18
19
20
21
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
